Guggenheim maintained a Buy rating on Merck (NYSE:MRK) shares but reduced the price target to $115 from $122. The adjustment follows a comprehensive review of the pharmaceutical giant's fourth-quarter ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Growing demand for tryptamine APIs stems from their anti-cancer potential, pharmaceutical uses, and role as a neurotransmitter modulator i ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

For the 10th anniversary of America’s Best Large and Midsize Employers, Forbes is recognizing 77 Best Employer ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

As per Intent Market Research, the Cell Analysis Market was valued at USD 19.2 billion in 2023-e and will surpass USD 38.4 billion by 2030; growing at a CAGR of 10.4% during 2024 - 2030.

Rising global population fuels the plant Genotyping Equipment market as demand grows for high-yield, resilient crops to ensure sustainable food production.

GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 33,776.08 Crore) operating in Pharmaceuticals sector. Laurus Labs Ltd. key Products/Revenue Segments ...